Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Han Si
Affiliation
Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei University
ORCID
Career Start Year
2003
Papers
36
H Index
22
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35308340
Enabling Efficient Genetic Manipulations in a Rare Actinomycete <i>Pseudonocardia alni</i> Shahu.
Front Microbiol
2022
35308340
Enabling Efficient Genetic Manipulations in a Rare Actinomycete <i>Pseudonocardia alni</i> Shahu.
Front Microbiol
2022
33355200
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.
Clin Cancer Res
2021
33257508
A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade.
Mol Cancer Res
2021
33200847
Brain-specific monoallelic expression of bovine UBE3A is associated with genomic position.
Anim Genet
2021
33355200
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.
Clin Cancer Res
2021
33200847
Brain-specific monoallelic expression of bovine UBE3A is associated with genomic position.
Anim Genet
2021
33257508
A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade.
Mol Cancer Res
2021
32817076
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.
Clin Cancer Res
2020
32817076
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.
Clin Cancer Res
2020
30955263
[Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
Zhonghua Bing Li Xue Za Zhi
2019
31684954
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
J Transl Med
2019
31624067
Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.
Cancer Immunol Res
2019
30955263
[Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
Zhonghua Bing Li Xue Za Zhi
2019
31684954
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
J Transl Med
2019
31624067
Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.
Cancer Immunol Res
2019
29518341
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
Am J Respir Crit Care Med
2018
30380422
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Cell Rep
2018
29518341
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
Am J Respir Crit Care Med
2018
30380422
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Cell Rep
2018
27132513
TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Oncogene
2016
27147817
RefCNV: Identification of Gene-Based Copy Number Variants Using Whole Exome Sequencing.
Cancer Inform
2016
27132513
TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Oncogene
2016
27455875
Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods.
J Mol Diagn
2016
27455875
Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods.
J Mol Diagn
2016
27147817
RefCNV: Identification of Gene-Based Copy Number Variants Using Whole Exome Sequencing.
Cancer Inform
2016
25478319
Genome-wide redistribution of BRD4 binding sites in transformation resistant cells.
Genom Data
2015
25911752
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.
J Immunol
2015
25784146
Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory disease.
Clin Immunol
2015
25478319
Genome-wide redistribution of BRD4 binding sites in transformation resistant cells.
Genom Data
2015
25911752
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.
J Immunol
2015
25784146
Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory disease.
Clin Immunol
2015
23455325
Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Oncogene
2014
25371364
Mesogenin 1 is a master regulator of paraxial presomitic mesoderm differentiation.
Development
2014
25515573
Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis.
Invest Ophthalmol Vis Sci
2014
24258200
Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation.
J Pathol
2014
23455325
Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Oncogene
2014
25515573
Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis.
Invest Ophthalmol Vis Sci
2014
25371364
Mesogenin 1 is a master regulator of paraxial presomitic mesoderm differentiation.
Development
2014
24258200
Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation.
J Pathol
2014
24098934
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.
Genome Biol
2013
24098934
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.
Genome Biol
2013
21576089
οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.
Cancer Res
2011
21576089
οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.
Cancer Res
2011
20531454
Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.
Kidney Int
2010
20978353
Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.
J Clin Invest
2010
20531454
Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.
Kidney Int
2010
20978353
Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.
J Clin Invest
2010
19037656
Disruption of the Gardos channel (KCa3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly.
Pflugers Arch
2009
19037656
Disruption of the Gardos channel (KCa3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly.
Pflugers Arch
2009
1 - 50 of 72
Column Actions
Search
Recommended Authors
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
0
Jing Chen
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year
2007
Number of shared co-authors
0
Tao Wei
Urumqi Friendship Hospital
Career Start Year
2005
Number of shared co-authors
0
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
0
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
1
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Sophia Derdak
Medical University of Vienna
Career Start Year
2001
Number of shared co-authors
0
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year
2001
Number of shared co-authors
0
David K Crossman
University of Alabama at Birmingham
Career Start Year
2000
Number of shared co-authors
0
Yan W Asmann
Mayo Clinic
Career Start Year
2000
Number of shared co-authors
0
Ming Zhan
Ningbo First Hospital, Zhejiang University
Career Start Year
2000
Number of shared co-authors
5
Chao Xing
University of Texas Southwestern Medical Center
Career Start Year
1999
Number of shared co-authors
0
Celine Lefebvre
The Scripps Research Institute
Career Start Year
1999
Number of shared co-authors
0
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year
1999
Number of shared co-authors
1
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year
1998
Number of shared co-authors
2
Fahd Al-Mulla
Dasman Diabetes Institute
Career Start Year
1998
Number of shared co-authors
0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Andrey Loboda
Merck & Co., Inc.
Career Start Year
1998
Number of shared co-authors
0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year
1997
Number of shared co-authors
0
Grace Lee
Bowdoin College
Career Start Year
1997
Number of shared co-authors
0
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
0
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year
1997
Number of shared co-authors
0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
2
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
0
Abdel G Elkahloun
National Human Genome Research Institute
Career Start Year
1990
Number of shared co-authors
5
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year
1989
Number of shared co-authors
0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
0
Bruce J Aronow
Cincinnati Children's Hospital Medical Center
Career Start Year
1975
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Zhong Chen
National Institute on Deafness and Other Communication Disorders
Co-authored papers
6
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Co-authored papers
6
Xinping Yang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
6
Katalin Susztak
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
5
Yansong Bian
Center for Cancer Research, National Cancer Institute
Co-authored papers
4
Rose-Anne Romano
State University of New York at Buffalo
Co-authored papers
3
Hatice Nida Sen
National Eye Institute
Co-authored papers
3
Satrajit Sinha
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Co-authored papers
3
Robert B Nussenblatt
National Eye Institute
Co-authored papers
3
Austin K Mattox
Howard Hughes Medical Institute
Co-authored papers
2
Bin Yan
The University of Hong Kong
Co-authored papers
2
Brandon W Higgs
Translational and Clinical Data Sciences
Co-authored papers
2
Steven K Lee
National Institute on Deafness and Other Communication Disorders
Co-authored papers
2
Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers
2
David B Thomas
Duke University
Co-authored papers
2
Hai Lu
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers
2
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Co-authored papers
1
Thomas E Carey
Kresge Hearing Research Institute, University of Michigan ann arbor
Co-authored papers
1
Elena Helman
Co-authored papers
1
Natalia Issaeva
The University of North Carolina at Chapel Hill
Co-authored papers
1
Hector Viadiu
All India Institute of Medical Sciences
Co-authored papers
1
Emiko Sano
0 SW US Veterans Hospital Road
Co-authored papers
1
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
1
Masako Suzuki
Co-authored papers
1
Alastair K Denniston
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers
1
Chris Morehouse
Oncology R&D Unit
Co-authored papers
1
Hao Sun
University of Illinois at Urbana-Champaign
Co-authored papers
1
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers
1
Ryan Chuang
David Geffen School of Medicine, university of california los angeles
Co-authored papers
1
Ruth Nussinov
Sackler School of Medicine, Tel Aviv University
Co-authored papers
1
1 - 30